BioWorld MedTech

July 23, 2014

Boston Scientific receives PMA for its Rebel Platinum Chromium BMS

Despite the adoption rates of drug-eluting stents (DES), device makers haven't totally abandoned bare metal stents (BMS). One only has to look at Boston Scientific's (Natick, Massachusetts) most recent product approval as evidence. Read More

World in Review: Oraya Therapeutics expanding AMD wet therapy into Europe

FDA releases documents under IMDRF's single audit program

EPs in Europe gain access to new FlexAbility catheter from St. Jude

Daily M&A: Kindred ups its offer for Gentiva to $17.25 a share, subject to 'diligence'

Agreements/Contracts: Christie NHS to join consortium to develop radiotherapy system

Patent Watch: Neodyne Biosciences receives Korean patent for treatment of Keloids

Hit Bits: New security consulting services aim to protect medical device cybersecurity

Briefly noted

Products

People in Places

MDD's Cardiology Extra

Today's news in brief

BioWorld

BioWorld briefs for May 20, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...